BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 191197)

  • 1. Loss of Fv-1 restriction in Balb/3T3 cells following infection with a single N tropic murine leukemia virus particle.
    Duran-Troise G; Bassin RH; Rein A; Gerwin BI
    Cell; 1977 Mar; 10(3):479-88. PubMed ID: 191197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of murine leukemia virus restriction in mammals.
    Besnier C; Ylinen L; Strange B; Lister A; Takeuchi Y; Goff SP; Towers GJ
    J Virol; 2003 Dec; 77(24):13403-6. PubMed ID: 14645596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Capsid-dependent lentiviral restrictions.
    Twentyman J; Emerman M; Ohainle M
    J Virol; 2024 Apr; 98(4):e0030824. PubMed ID: 38497663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression levels of Fv1: effects on retroviral restriction specificities.
    Li W; Yap MW; Voss V; Stoye JP
    Retrovirology; 2016 Jun; 13(1):42. PubMed ID: 27342974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiretroviral restriction factors in mice.
    Nair S; Rein A
    Virus Res; 2014 Nov; 193():130-4. PubMed ID: 25018022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Murine leukemia viruses: objects and organisms.
    Rein A
    Adv Virol; 2011; 2011():403419. PubMed ID: 22312342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Host restriction factors blocking retroviral replication.
    Wolf D; Goff SP
    Annu Rev Genet; 2008; 42():143-63. PubMed ID: 18624631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRIM5 alpha cytoplasmic bodies are highly dynamic structures.
    Campbell EM; Dodding MP; Yap MW; Wu X; Gallois-Montbrun S; Malim MH; Stoye JP; Hope TJ
    Mol Biol Cell; 2007 Jun; 18(6):2102-11. PubMed ID: 17392513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteasome inhibition reveals that a functional preintegration complex intermediate can be generated during restriction by diverse TRIM5 proteins.
    Anderson JL; Campbell EM; Wu X; Vandegraaff N; Engelman A; Hope TJ
    J Virol; 2006 Oct; 80(19):9754-60. PubMed ID: 16973579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. All three variable regions of the TRIM5alpha B30.2 domain can contribute to the specificity of retrovirus restriction.
    Ohkura S; Yap MW; Sheldon T; Stoye JP
    J Virol; 2006 Sep; 80(17):8554-65. PubMed ID: 16912305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteasome inhibitors uncouple rhesus TRIM5alpha restriction of HIV-1 reverse transcription and infection.
    Wu X; Anderson JL; Campbell EM; Joseph AM; Hope TJ
    Proc Natl Acad Sci U S A; 2006 May; 103(19):7465-70. PubMed ID: 16648264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclophilin A and TRIM5alpha independently regulate human immunodeficiency virus type 1 infectivity in human cells.
    Sokolskaja E; Berthoux L; Luban J
    J Virol; 2006 Mar; 80(6):2855-62. PubMed ID: 16501094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retroviral restriction factors Fv1 and TRIM5alpha act independently and can compete for incoming virus before reverse transcription.
    Passerini LD; Keckesova Z; Towers GJ
    J Virol; 2006 Mar; 80(5):2100-5. PubMed ID: 16474118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Capsid processing requirements for abrogation of Fv1 and Ref1 restriction.
    Dodding MP; Bock M; Yap MW; Stoye JP
    J Virol; 2005 Aug; 79(16):10571-7. PubMed ID: 16051849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Murine T cells potently restrict human immunodeficiency virus infection.
    Baumann JG; Unutmaz D; Miller MD; Breun SK; Grill SM; Mirro J; Littman DR; Rein A; KewalRamani VN
    J Virol; 2004 Nov; 78(22):12537-47. PubMed ID: 15507641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In defense of the cell: TRIM5alpha interception of mammalian retroviruses.
    Lee K; KewalRamani VN
    Proc Natl Acad Sci U S A; 2004 Jul; 101(29):10496-7. PubMed ID: 15252204
    [No Abstract]   [Full Text] [Related]  

  • 17. Species-specific tropism determinants in the human immunodeficiency virus type 1 capsid.
    Hatziioannou T; Cowan S; Von Schwedler UK; Sundquist WI; Bieniasz PD
    J Virol; 2004 Jun; 78(11):6005-12. PubMed ID: 15140998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Capsid-dependent and -independent postentry restriction of primate lentivirus tropism in rodent cells.
    Hatziioannou T; Cowan S; Bieniasz PD
    J Virol; 2004 Jan; 78(2):1006-11. PubMed ID: 14694132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restriction of multiple divergent retroviruses by Lv1 and Ref1.
    Hatziioannou T; Cowan S; Goff SP; Bieniasz PD; Towers GJ
    EMBO J; 2003 Feb; 22(3):385-94. PubMed ID: 12554640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of a transient assay for studying the genetic determinants of Fv1 restriction.
    Bock M; Bishop KN; Towers G; Stoye JP
    J Virol; 2000 Aug; 74(16):7422-30. PubMed ID: 10906195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.